Impedimed Ltd Net Assets

Latest as of June 2026: AU$10.19 Million AUD ≈ $7.21 Million USD

Impedimed Ltd net assets. Based on the latest financial reports, Impedimed Ltd (IPD) has net assets worth AU$10.19 Million AUD (≈ $7.21 Million USD) as of June 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (AU$34.66 Million ≈ $24.52 Million USD) and total liabilities (AU$24.47 Million ≈ $17.32 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore how fast is Impedimed Ltd growing its equity to track the company's year-over-year net asset growth rate.

Key Net Assets Metrics

Metric Value
Current Net Assets AU$10.19 Million
% of Total Assets 29.39%
Annual Growth Rate N/A
5-Year Change -80.04%
10-Year Change -82.67%
Growth Volatility 68.26

Net Assets of Impedimed Ltd (2006–2026)

Net assets of Impedimed Ltd from 2006 to 2026. This chart illustrates how Impedimed Ltd's net assets have evolved over time, based on quarterly financial data. See net asset quality index of Impedimed Ltd to measure how much of total assets are equity-financed.

Annual Net Assets for Impedimed Ltd (2006–2026)

The table below shows the annual net assets of Impedimed Ltd from 2006 to 2026. For live market cap and overall valuation, see Impedimed Ltd market cap and net worth.

Year Net Assets Change
2026-06-30 AU$10.19 Million
≈ $7.21 Million		 -50.30%
2025-06-30 AU$20.50 Million
≈ $14.50 Million		 -49.69%
2024-06-30 AU$40.74 Million
≈ $28.83 Million		 -33.08%
2023-06-30 AU$60.88 Million
≈ $43.08 Million		 +19.27%
2022-06-30 AU$51.04 Million
≈ $36.12 Million		 +100.06%
2021-06-30 AU$25.51 Million
≈ $18.05 Million		 -6.75%
2020-06-30 AU$27.36 Million
≈ $19.36 Million		 +73.34%
2019-06-30 AU$15.79 Million
≈ $11.17 Million		 -55.91%
2018-06-30 AU$35.80 Million
≈ $25.33 Million		 -39.11%
2017-06-30 AU$58.80 Million
≈ $41.60 Million		 -31.03%
2016-06-30 AU$85.25 Million
≈ $60.32 Million		 +144.72%
2015-06-30 AU$34.84 Million
≈ $24.65 Million		 +157.44%
2014-06-30 AU$13.53 Million
≈ $9.57 Million		 +27.73%
2013-06-30 AU$10.59 Million
≈ $7.50 Million		 -38.80%
2012-06-30 AU$17.31 Million
≈ $12.25 Million		 -16.31%
2011-06-30 AU$20.68 Million
≈ $14.63 Million		 -6.96%
2010-06-30 AU$22.23 Million
≈ $15.73 Million		 +120.82%
2009-06-30 AU$10.07 Million
≈ $7.12 Million		 -18.16%
2008-06-30 AU$12.30 Million
≈ $8.70 Million		 -36.61%
2007-06-30 AU$19.40 Million
≈ $13.73 Million		 +514.69%
2006-06-30 AU$-4.68 Million
≈ $-3.31 Million		 --

Equity Component Analysis

This analysis shows how different components contribute to Impedimed Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 34728738100.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Impedimed Ltd Net Assets Breakdown (June 2026)

Impedimed Ltd net assets breakdown by equity component as of June 2026.

Component Amount Percentage
Common Stock AU$349.86 Million 3434.38%
Other Comprehensive Income AU$39.42 Million 386.99%
Total Equity AU$10.19 Million 100.00%

Impedimed Ltd Competitors by Market Cap

The table below lists competitors of Impedimed Ltd ranked by their market capitalization.

Company Market Cap
General Environmental Conservation Public Company Limited
BK:GENCO
 $10.37 Million
Sheffield Resources Ltd
AU:SFX
 $10.37 Million
CodeLab Capital A/S
OL:CODE
 $10.37 Million
Lithium Plus Minerals Ltd
AU:LPM
 $10.37 Million
Modernland Realty Ltd Tbk
JK:MDLN
 $10.37 Million
NowVertical Group Inc
V:NOW
 $10.36 Million
SAG Holdings Limited
NASDAQ:SAG
 $10.35 Million
RPCG PCL -NVDR- BA 1
F:W8M1
 $10.35 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Impedimed Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2025 to 2026, total equity changed from 20,496,000 to 10,187,000, a change of -10,309,000 (-50.3%).
  • Net loss of 24,907,000 reduced equity.
  • Share repurchases of 1,768,000 reduced equity.
  • New share issuances of 15,300,000 increased equity.
  • Other comprehensive income increased equity by 885,000.
  • Other factors increased equity by 181,000.

Equity Change Factors (2025 to 2026)

Factor Impact Contribution
Net Income AU$-24.91 Million -244.5%
Share Repurchases AU$1.77 Million -17.36%
Share Issuances AU$15.30 Million +150.19%
Other Comprehensive Income AU$885.00K +8.69%
Other Changes AU$181.00K +1.78%
Total Change AU$- -50.30%

Book Value vs Market Value Analysis

This analysis compares Impedimed Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 0.84x
  • The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
  • The price-to-book ratio has increased from 0.02x to 0.84x over the analyzed period, suggesting growing market confidence.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2007-06-30 AU$0.23 AU$0.00 x
2008-06-30 AU$0.17 AU$0.00 x
2009-06-30 AU$0.10 AU$0.00 x
2010-06-30 AU$0.18 AU$0.00 x
2011-06-30 AU$0.13 AU$0.00 x
2012-06-30 AU$0.10 AU$0.00 x
2013-06-30 AU$0.05 AU$0.00 x
2014-06-30 AU$0.06 AU$0.00 x
2015-06-30 AU$0.12 AU$0.00 x
2016-06-30 AU$0.27 AU$0.00 x
2017-06-30 AU$0.16 AU$0.00 x
2018-06-30 AU$0.09 AU$0.00 x
2019-06-30 AU$0.04 AU$0.00 x
2020-06-30 AU$0.05 AU$0.00 x
2021-06-30 AU$0.02 AU$0.00 x
2022-06-30 AU$0.03 AU$0.00 x
2023-06-30 AU$0.03 AU$0.00 x
2024-06-30 AU$0.02 AU$0.00 x
2025-06-30 AU$0.01 AU$0.00 x
2026-06-30 AU$0.00 AU$0.00 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Impedimed Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): -244.50%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -170.44%
  • • Asset Turnover: 0.42x
  • • Equity Multiplier: 3.40x
  • Recent ROE (-244.50%) is below the historical average (-80.93%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2008 -79.30% -422.00% 0.16x 1.18x AU$-10.98 Million
2009 -139.34% -468.85% 0.23x 1.30x AU$-15.03 Million
2010 -51.29% -313.33% 0.15x 1.12x AU$-13.62 Million
2011 -71.66% -381.32% 0.17x 1.10x AU$-16.89 Million
2012 -71.30% -419.08% 0.15x 1.13x AU$-14.07 Million
2013 -79.89% -309.70% 0.23x 1.12x AU$-9.52 Million
2014 -58.64% -225.36% 0.24x 1.11x AU$-9.29 Million
2015 -42.47% -305.47% 0.13x 1.09x AU$-18.28 Million
2016 -30.47% -448.63% 0.06x 1.06x AU$-34.51 Million
2017 -46.89% -478.17% 0.09x 1.09x AU$-33.45 Million
2018 -76.10% -821.22% 0.08x 1.16x AU$-30.83 Million
2019 -152.02% -577.38% 0.18x 1.43x AU$-25.57 Million
2020 -78.13% -372.36% 0.17x 1.21x AU$-24.11 Million
2021 -81.16% -246.24% 0.25x 1.34x AU$-23.26 Million
2022 -38.94% -188.09% 0.18x 1.15x AU$-24.98 Million
2023 -33.71% -180.90% 0.17x 1.13x AU$-26.61 Million
2024 -48.57% -191.78% 0.22x 1.15x AU$-23.86 Million
2025 -113.37% -182.62% 0.31x 2.03x AU$-25.29 Million
2026 -244.50% -170.44% 0.42x 3.40x AU$-25.93 Million

Industry Comparison

This section compares Impedimed Ltd's net assets metrics with peer companies in the Medical Devices industry.

Industry Context

  • Industry: Medical Devices
  • Average net assets among peers: $86,522,583
  • Average return on equity (ROE) among peers: -38.54%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Impedimed Ltd (IPD) AU$10.19 Million -79.30% 2.40x $10.37 Million
4DMEDICAL Ltd (4DX) $83.36 Million -25.70% 0.11x $978.43 Million
Adherium Ltd (ADR) $5.54 Million -181.40% 0.54x $2.60 Million
Aroa Biosurgery Ltd (ARX) $15.23 Million 0.00% 0.29x $120.22 Million
Atomo Diagnostics Ltd (AT1) $-4.89 Million 0.00% 0.00x $8.94 Million
Avita Medical Inc (AVH) $12.96 Million -89.99% 0.20x $188.51 Million
Anteris Technologies Global Corp (AVR) $1.24 Million -94.76% 0.13x $581.11 Million
Control Bionics Ltd (CBL) $5.05 Million -38.22% 0.07x $18.83 Million
Cardiex Ltd (CDX) $792.00K 0.00% 0.97x $13.23 Million
Compumedics Ltd (CMP) $20.05 Million 6.51% 0.46x $33.22 Million
Cochlear Ltd (COH) $725.90 Million 38.12% 0.90x $6.56 Billion

About Impedimed Ltd

AU:IPD Australia Medical Devices
Market Cap
$10.37 Million
AU$14.65 Million AUD
Market Cap Rank
#26837 Global
#1235 in Australia
Share Price
AU$0.00
Change (1 day)
+0.00%
52-Week Range
AU$0.00 - AU$0.04
All Time High
AU$1.68
Categories
Companies in Australia Medical Devices
About

ImpediMed Limited, a medical technology company, engages in the development, manufacture, and sale of bioimpedance spectroscopy (BIS) systems and software services in Australia, Europe, North America, and internationally. The company offers SOZO Digital Health Platform which transforms fluid status and tissue composition into insights with a single scan; L-Dex Analysis for Lymphedema, designed fo… Read more